The aim of Bruno's company, Blend, is to empower veterinary hospitals to understand their role in pipeline development and to create opportunities for leaders and their teams to learn about how to...
The objective of this study was to evaluate the use of gabapentin as an adjuvant to carprofen for the management of postoperative pain following tibial plateau levelling osteotomy surgery.
The American Heartworm Society conducts an incidence survey every three years
The leading states for heartworm incidence continue to be those around the lower Mississippi Delta, which has a climate where mosquitos thrive along with the presence of untreated dogs and wildlife...
Research in canine cancer has led to some promising findings, including liquid biopsy testing to help detect genomic alterations in cell-free DNA fragments in blood. This is a non-invasive means to...
Maropitant Citrate is an antiemetic drug that contains the same active ingredient (maropitant citrate) in the same concentration and dosage form as the approved brand name drug product, Cerenia...
Systematic screening of serum insulin-like growth factor 1 and total thyroxine was performed in all cats diagnosed with DM at referral centers in Buenos Aires between February 2020 and February 2022.
Evaluating regeneration is essential for the classification and differential diagnosis of anemia in dogs. Early detection of regeneration is challenging in anemic dogs.
The American Association of Pet Parents was founded in 2020 with a goal to help people navigate online information in a way that avoids confusion and...
Researchers aimed to determine whether one larger or two smaller diameter pins used for tibial tuberosity avulsion fracture stabilization provides greater axial tensile strength and stiffness when...
Librela is the first and only once-monthly, anti-Nerve Growth Factor monoclonal antibody treatment for canine osteoarthritis pain. It is safe and effective in providing long-term control of OA pain...
Congenital portosystemic shunts are among the two most common congenital vascular anomalies of the liver in small animals, along with primary hypoplasia of the portal vein without portal...
On May 1, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1, the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats.